Incidence of antiresorptive agent-related osteonecrosis of the jaw: A multicenter retrospective epidemiological study in Hyogo Prefecture, Japan-Reference-Cited by-同舟云学术

Incidence of antiresorptive agent-related osteonecrosis of the jaw: A multicenter retrospective epidemiological study in Hyogo Prefecture, Japan

Published:2022-11 Issue: Volume: Page:
ISSN:1991-7902
Container-title:Journal of Dental Sciences
language:en
Short-container-title:Journal of Dental Sciences

Author:

Nashi Masanori^ORCID,Kishimoto Hiromitsu,Kobayashi Masaki,Tachibana Akira,Suematsu Motoo,Fujiwara Shigeyoshi,Ota Yoshiyuki,Hashitani Susumu,Shibatsuji Takeshi,Nishida Tetsuya,Fujimura Kazuma,Furudoi Shungo,Ishida Yoshiki,Ishii Shoichiro,Fujita Tsuyoshi,Iwai Soichi,Shigeta Takashi,Harada Takeshi^ORCID,Miyai Daisuke,Takeda Daisuke,Akashi Masaya,Noguchi Kazuma,Takenobu Toshihiko^ORCID

Publisher

Elsevier BV

Subject

General Dentistry

Reference28 articles.

1. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic (1);Marx;J Oral Maxillofac Surg,2003

2. Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials;Qi;Int J Clin Oncol,2014

3. Persistent bone resorption lacunae on necrotic bone distinguish bisphosphonate-related osteonecrosis of jaw from denosumab-related osteonecrosis;Aoki;J Bone Miner Metabol,2021

4. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update;Ruggiero;J Oral Maxillofac Surg,2014

5. Antiresorptive agent-related osteonecrosis of the jaw: position paper 2017 of the Japanese allied committee on osteonecrosis of the jaw;Yoneda;J Bone Miner Metabol,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A study of peri-implant tissue clinical parameters in patients starting anti-osteoporosis medication after existing implant function: a prospective cohort study;2024-07-18

2. Cumulative incidence and risk factors for medication-related osteonecrosis of the jaw during long-term prostate cancer management;Scientific Reports;2024-06-11

3. Role of Actinomyces spp. and related organisms in the development of medication-related osteonecrosis of the jaw (MRONJ): Clinical evidence based on a case series;European Journal of Microbiology and Immunology;2023-12-21

4. Bone resection methods in medication-related osteonecrosis of the jaw in the mandible: An investigation of 206 patients undergoing surgical treatment;Journal of Dental Sciences;2023-10

5. Risk factors for the development of medication-related osteonecrosis of the jaw and effects of tooth extraction with local infection;Journal of Dental Sciences;2023-10